SG Americas Securities
PMVP icon

SG Americas Securities’s PMV Pharmaceuticals PMVP Stock Holding History

SG Americas Securities’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,994
Closed -$65K – 3336
2023
Q4 		$65K Buy
+20,994
New +$55.6K ﹤0.01% 2873
2022
Q3 		– Sell
-64,830
Closed -$924K – 3470
2022
Q2 		$924K Buy
+64,830
New +$944K 0.01% 1369
2022
Q1 		– Sell
-91,464
Closed -$2.11M – 3330
2021
Q4 		$2.11M Buy
91,464
+81,822
+849% +$1.98M 0.01% 1034
2021
Q3 		$287K Buy
+9,642
New +$308K ﹤0.01% 2982

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

SG Americas Securities's PMVP Position: Q1 2024 in Review

SG Americas Securities sold out of PMV Pharmaceuticals (PMVP) in Q1 2024, closing a stake of 20,994 shares — an estimated $65K sold.

SG Americas Securities first reported a position in PMVP in Q3 2021 and held it in 4 quarters. The position peaked at $2.11M in Q4 2021. 99 funds tracked by Wall St. Rank hold PMVP as of Q1 2024.

  • SG Americas Securities reported no remaining PMV Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 20,994 PMV Pharmaceuticals shares in Q1 2024, an estimated $65K.
  • SG Americas Securities first reported a position in PMV Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • SG Americas Securities's PMV Pharmaceuticals position peaked at $2.11M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.